Conference: Pharma Preparing Next Marketing Assault

[Guest guest]

SSRI-Research@

Fri, 27 Jan 2006 16:42:25 -0500

[sSRI-Research] Conference: Pharma Preparing Next Marketing

Assault

 

 

 

 

Conference: Pharma Preparing Next Marketing Assault

 

ALLIANCE FOR HUMAN RESEARCH PROTECTION (AHRP)

Promoting Openness, Full Disclosure, and Accountability

www.ahrp.org

 

FYI

 

Pharmaceutical Marketing Sumit: for anyone who wants to gain insight

into how Big Pharma gains a " clear edge on conqueing untapped market

potential " -- or put another way--how 25 Pharma companies persuade

" untapped " populations they're sick- for which each has a new drug fix.

 

 

Contact: Vera Hassner Sharav

212-595-8974

veracare

 

Press Release Source: Strategic Research Institute

 

25 Different Pharma Companies to Present at Conference on

Patient-Level Data for Improving Marketing Effectiveness to take Place

April 4-5, 2006 New Brunswick, N.J.

 

Thursday January 26, 8:55 am ET

 

NEW YORK, Jan. 26 /PRNewswire/ -- Strategic Research Institute is

pleased to announce the upcoming Patient Level Data conference

scheduled to take place on April 4-5, 2006 in New Brunswick, NJ.

 

An agenda fully-loaded with big pharma participants, this conference

offers the opportunity to understand & learn about the most effective

best practices and reap the benefits on adopting this new strategic

tool. In sum, PLD accelerates pharma marketers strategic decision

making and marketing effectiveness which gives them the clear edge on

conquering untapped market potential.

 

The future direction of PLD and how its impact affects the other

elements of the marketing mix will be reflected upon the latest

sessions on:

 

1) Privacy laws and how they affect PLD, Jessica Blazer, Senior

Attorney,

Privacy Office, WYETH PHARMACEUTICALS; Hilary Wandall, Director,

Corporate Legal/Merck Privacy Office, MERCK & CO., INC.

 

2) Opted-in patient level data, Jim Hoch, Independent Consultant,

ACCESS

BIOTECH; Carl V. Asche, Ph.D., Research Associate Professor,

Department

of Pharmacotherapy, UNIVERSITY OF UTAH COLLEGE OF PHARMACY

 

3) Big Pharma's views on longitudinal data, Mohan Bala, Director,

Outcomes

Research, CENTOCOR; Vladimir Castillo, Associate Director of

Database

Marketing & Analytics, BRISTOL-MYERS SQUIBB; Moreshwar Deshpande,

Manager, Forecasting, AMGEN; Anshuman Panigrahi, Manager,

Management

Science Business, NOVARTIS PHARMACEUTICALS

 

4) Opportunities to improve and enhance PLD- pharma & partner

interactive

panel, Charley Beever, Vice President, BOOZ ALLEN HAMILTON; Barbara

Edelman Lewis, Ph.D., MHA, Director, Health Economics and Outcomes

Research, ASTRAZENECA; Jesse Ma, Team Leader Local Market

Optimization

& Decision Support, ELI LILLY & COMPANY; Ganesh Vedarajan,

Principal,

ZS ASSOCIATES

 

The conference features presenters from the industry from large,

medium and small pharmaceutical manufacturers of marketing

information. The complete list of presenters includes: Amgen, Amylin

Pharmaceuticals, AstraZeneca, Bristol-Myers Squibb, Centocor, Inc.,

Coley, Daiichi, Elan Pharmaceuticals, Eli Lilly & Company, Genzyme

Corporation, GlaxoSmithKline, Indevus, Johnson & Johnson, King

Pharmaceuticals, MedImmune, Merck & Co., Ortho-McNeil Janssen Pharma,

Pfizer, Inc., Millennium Pharmaceuticals, Novartis, Sankyo,

Sanofi-Aventis, Serono, Solvay Pharmaceuticals, Vertex Pharmaceuticals

and Wyeth.

 

This event will be part of the Pharmaceutical Marketing Summit (PMS),

a 6-conference shared opening session that features high-level

executive panels on some of the most press marketing topics, namely,

strategic marketing, branding, emerging and mid-sized company

marketing challenges, managed cared/MMA, and global marketing. The

conference website is www.srinstitute.com/pms.

 

400-600 high-level Pharma delegates are expected to attend the larger

PMS; PLD delegates will be permitted to attend sessions from all

concurrent meetings during its duration as well as the socializing and

networking events, and nightly entertainment planned to facilitate

speaker and attendee mixing.

 

A special rate for pharmaceutical company executive delegates has been

implemented for the all 6 conferences and all delegates may benefit

from registering early on and in groups for the greatest saving.

 

To request the Patient-Level Data agenda in PDF, contact Ed Drilon,

the organizer and Vice President of Life Sciences at Strategic

Research Institute at edrilon.

 

Sponsors and exhibitors are urged to book space early for best booth

placement. Space is allocated on a first-come, first-serve basis, and

features space up to 10 x 10, passes to all the sessions and events

and other benefits. Join lead sponsors PDI, Inc and Campbell Alliance

for even greater exposure through a variety of other options all of

which provide for optional booth space and passes. Contact Mark Alexay

at malexay or 212.967.0095, extension 251 to determine

what level of exposure works best for you.

 

To become a media partner, please contact Cheryl Kahan-Radhuber at

ckahan-radhuber.

 

_____

 

 

Source: Strategic Research Institute